{
  "hash": "799b8b68c6ec06bb",
  "original_length": 66658,
  "summary_length": 2666,
  "summary": "The U.S. District Court for the Western District of Ohio today entered a final judgment against Ohio Attorney General Jeff McClain, ordering him to conduct a fair and impartial review of the state's sales tax laws.  The SEC's complaint, filed in federal court in Columbus, Ohio on May 20, 2016, alleges that the Ohio Department of Taxation (DTA) improperly imposed a sales tax on feminine hygiene products, including tampons and pads, in violation of the antifraud provisions of Section 17(a) of the Securities Act of 1933.  According to the complaint, the DTA violated the federal securities laws by failing to apply a strict scrutiny analysis to certain of the products.  For example, the complaint alleges that Ohio's tax laws impose a tax on tampons, pads, and other products that do not meet the requirements of the federal sales tax.  Without admitting or denying the allegations of the complaint in the SEC's action, the Ohio Secretary of State's Office has issued an order suspending the imposition of the sales tax and ordering the Department of Justice to conduct an examination of the exemption provisions.  In its order, the court also ordered the Ohio secretary of state to provide an explanation for why the exemption was not applied to all of the items in question.   The court's order, which is subject to court approval, reserves the issue of whether the exemption is reasonable and reasonable to determine whether it is appropriate to proceed with the litigation.  On May 21, 2018, the Court granted the request for a preliminary injunction against future violations of the anti-deterrent provisions of Sections 5(a), 5(c), and 5(d) the Securities Exchange Act of 1934 (\"Exchange Act\") and Rules 5b-5, 5d-1, and (4) and (5) thereunder. The court also granted the court's request for an asset freeze and a temporary restraining order against further violations of Section 5 of the Exchange Act, ordering the payment of a civil penalty in the amount of $1,000, and imposing a $25,000 civil penalty against each of the defendants. The order also prohibits the issuance of an officer-and-director bar, and prohibits the purchase, sale, or promotion of any product that is not subject to the federal or state securities laws. In addition, the order prohibits the sale, purchase, offer, or sale of any type of medical equipment, regardless of whether it meets the federal, state, or local securities laws, and requires the exemption to be subject to reasonable and stringent scrutiny.  Additionally, the orders prohibit the issuance or purchase of any medical device without a prescription, and require the exemption of any safety or effectiveness of the"
}